Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Gore, Spectrumedics, Stereotaxis.

Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Adlai Nortye, Arbormed Harbour Biomed, Biogen, Hyloris, Juangsu Aosaikang, Samsung,Takeda Pharmaceutical, Yantai Lannacheng, Xoma Royalty.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Huonslab, Incyte Biosciences, Kalvista, Regeneraon, Samsung Bioepis, SN Bioscience, Zai Lab.

New hires and promotions in the med-tech industry, including: Evogene.

Biopharmas in Asia-Pacific raising money in public or private financings: Biomx, Innocan.

The top 10 med-tech stock gainers and losers for the week.

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Outlook.

Biopharma happenings, including deals and partnerships, and other news in brief: Biogen, Genmab, Samsung Bioepis, Roche, Valneva.

Biopharmas raising money in public or private financings, including: Alvotech, Hemostemix, Innocan.

New hires and promotions in the biopharma industry, including: Evotec, Genelux, Mesoblast.